07. June 2019
The introduction of checkpoint inhibitors in clinical oncology has transformed the way we treat cancer ...
author: Dr. Monika Baehner
Dr. Ralf Huss, Chief Medical Officer at Definiens, explains how the ...
author: Dr. Ralf Huss
2018 will be remembered as a decisive year for immuno-oncology. In particular, Nobel Prize winners James ...
author: Dr. Ralf Huss
Immuno-oncology is changing the way we treat cancer. The Tissue Phenomics Blog brings you the latest in the development to better understand the tumor microenvironment using biomarker analysis, IHC, and IF.
Stay up to date by subscribing to our newsletter.